Navigation Links
CU Cancer Center study: Young patients with metastatic colorectal cancer at higher risk
Date:9/30/2013

risk changes as people age, rather than simply comparing one group (patients younger than 40) with another group (patients older than 40)," Lieu said.

Previous studies in this field have split the population into two mutually exclusive groups, establishing rigid limits between those patients younger than 40 or 50 and those older than that age. The new research, however, did not use such a cut-off approach and includes data spanning all ages.

"The reason we did this is we believe a 49-year-old patient with colorectal cancer may be different than a 20-year-old. By including them in the same group of people younger than 50 years old, we might be mistakenly considering them the same," said Lieu.

Lieu and his colleagues analyzed information from a database of clinical trials in advanced colorectal cancer supported by the French "Aide et Recherche en Cancrologie Digestive" Foundation (ARCAD), which includes the 20,034 patients from 24 phase III clinical trials who were on their first treatment for the disease. There was additional patient data in which patients might be on second or third line treatment, having not responded to their initial therapy. Out of these patients, 20,011 were evaluable for analysis of survival time and time until the disease progressed.

"Analysis of this incredibly large population of patients has allowed us to answer meaningful questions, such as the outcomes of young versus older patients. Our results show young age is associated with worse overall survival and progression-free survival," said Lieu. "Young patients with metastatic colorectal cancer represent a group who are at high risk for treatment failure."

Despite the comprehensive nature of the study, more research will be required to identify why colorectal cancer in younger people appears to be more aggressive. Lieu and collaborators from University of Texas MD Anderson Cancer Center are now looking at the biological differences that may ac
'/>"/>

Contact: Erika Matich
erika.matich@ucdenver.edu
303-724-1528
University of Colorado Denver
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. New approaches to testing cancer drugs needed -- ESMO press commentary
2. Cancer/Tumor Profiling Market (Personalized Medicine, Biomarker Discovery, Prognosis, Research) Worth $35.03 Billion by 2018 – New Report by MarketsandMarkets
3. New Kantar Health Data Show Number of Newly Diagnosed Breast Cancer Patients in China Will Surpass U.S. by 2015
4. Mesothelioma Awareness Day Sheds Light on Deadly Cancer
5. Diet Doc Hormone Diets & Weight Loss Plans Introduce Hormone Therapy Treatments to Target Belly Fat, the Cause of Many Symptoms of Cancer
6. Chicago Medical Malpractice Lawyers of Salvi, Schostok & Pritchard P.C. Call Attention to Issue of Cancer Misdiagnosis
7. Voices Against Brain Cancer Discusses Recent Finding By Johns Hopkins Researchers Concerning Brain Tumor Treatments
8. Penn Medicine researcher unveils findings on 2 new weapons against thyroid cancer
9. Combining Chinese and Western medicine could lead to new cancer treatments
10. Actos Bladder Cancer Lawsuit: Bernstein Liebhard LLP Comments on Outcome of Nation’s Second Actos Lawsuit Trial
11. Colorectal cancer screening works
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2014)... November 23, 2014 The report, ... 2006 to 2020 - Asia-Pacific” provides quantitative analysis ... market segments: minimally invasive body contouring devices, non-invasive ... analysis includes market size data by revenue and ... following countries: China, Japan, South Korea, Australia and ...
(Date:11/23/2014)... 2014 (HealthDay News) -- The holidays can be a ... overload can trigger major meltdowns, an expert says. ... of circumstances, but when you have children with special ... occupational therapy professor at University of the Sciences in ... best to let your hosts or visitors know what ...
(Date:11/23/2014)... 23, 2014 More than two dozen ... a federal litigation involving Byetta lawsuits ( http://www.byettalawsuit2013.com/ ), ... Liebhard LLP reports. , A Case List updated ... class of Type 2 diabetes medications referred to as ... District Court, Southern District of California, where a federal ...
(Date:11/23/2014)... November 23, 2014 Syngenta lawsuits are ... behalf of farmers and agribusinesses that have allegedly incurred ... commercialize Agrisure Viptera and Agrisure Duracade, genetically modified ... approved for sale in China. According to a report ... virtually ban U.S. corn imports. Because China is the ...
(Date:11/22/2014)... 2014 A new AlignLife Chiropractic & ... the downtown Greenville area. Dr. Chelsea Sineath, owner and ... to open her own clinic after working in another ... patients. , AlignLife believes that the body can ... focus on chiropractic care and rehabilitation to allow the ...
Breaking Medicine News(10 mins):Health News:Aesthetic Lasers and Energy Devices Market in APAC (China, Japan, South Korea, Australia and India) to 2020 2Health News:Aesthetic Lasers and Energy Devices Market in APAC (China, Japan, South Korea, Australia and India) to 2020 3Health News:Aesthetic Lasers and Energy Devices Market in APAC (China, Japan, South Korea, Australia and India) to 2020 4Health News:Holidays Can Be Sensory Overload for Kids With Autism 2Health News:California Federal Court Overseeing Byetta Lawsuits, Other Incretin Mimetic Claims Adds New Cases in November, Bernstein Liebhard LLP Reports 2Health News:California Federal Court Overseeing Byetta Lawsuits, Other Incretin Mimetic Claims Adds New Cases in November, Bernstein Liebhard LLP Reports 3Health News:California Federal Court Overseeing Byetta Lawsuits, Other Incretin Mimetic Claims Adds New Cases in November, Bernstein Liebhard LLP Reports 4Health News:Syngenta Lawsuits Being Investigated by Wright & Schulte LLC, Following China’s Rejection of Corn Shipments Tainted with Unapproved GMO Seed 2Health News:Syngenta Lawsuits Being Investigated by Wright & Schulte LLC, Following China’s Rejection of Corn Shipments Tainted with Unapproved GMO Seed 3Health News:AlignLife of Downtown Greenville is Now Open and Accepting New Patients 2
... 28 (HealthDay News) -- While the hormone oxytocin makes people ... study shows. Oxytocin -- a naturally occurring hormone that ... an important role in social behavior. Increased levels of the ... overall caring, generosity and trust, but it hasn,t been known ...
... of the most spectacular migrations on Earth is that of ... Acknowledged as one of the wonders of the natural world, ... five-kilometre breeding migration. Now, scientists have discovered the key to ... a team led by the late Professor Steve Morris from ...
... Traumatic brain injury, currently considered a singular event ... is instead the beginning of an ongoing process that ... other diseases and disorders that can reduce life expectancy, ... Branch at Galveston. As such, traumatic brain injury ...
... study not only has confirmed that children who have ... more prone to emotional problems, but many of those ... or peer violence that could exacerbate those issues. ... on top of exposure to disaster had more anxiety, ...
... a small and cheap-to-build unmanned aerial vehicle (UAV) intended ... reduce risks to material and human lives. The seaplane ... plane to fly in severe weather conditions. The resulting ... payload of up to 40 kg. It is equipped ...
... single cochlear implant capable of giving sound in both ears ... of the South of England Cochlear Implant Centre (SOECIC), based ... is an electronic device that can help both adults and ... has two parts: an internal receiver/stimulator package and electrode array, ...
Cached Medicine News:Health News:Oxytocin Increases Trust, Not Gullibility 2Health News:Scientists discover key to Christmas Island's red crab migration 2Health News:Researchers urge reclassification of traumatic brain injury as chronic disease 2Health News:Researchers urge reclassification of traumatic brain injury as chronic disease 3Health News:Researchers urge reclassification of traumatic brain injury as chronic disease 4Health News:Victimized children involved with disasters more likely to have mental health issues 2Health News:Victimized children involved with disasters more likely to have mental health issues 3Health News:Shape-shifting robot plane offers safer alternative for maritime rescue 2Health News:Shape-shifting robot plane offers safer alternative for maritime rescue 3Health News:Southampton to conduct UK's first cochlear implant operation to give sound in both ears 2
(Date:11/21/2014)... , Nov. 21, 2014 ... the European Medicines Agency (EMA) has granted ... company,s lead product candidate, for the treatment ... a rare, severely disabling genetic disease characterized ... swelling (flare-ups) and new abnormal bone formation. ...
(Date:11/21/2014)... 20, 2014  RedRick Technologies, a provider of ... room environment guidance, has helped the new Penn ... room, which may also serve as a model ... "In line with the tenets ... Radiology,s Imaging 3.0 ™ initiative, the new ...
(Date:11/21/2014)... CORAL GABLES, Fla. , Nov. 20, 2014 /PRNewswire/ ... working to become the first U.S. commercial producer of ... signed a contract with INVAP to design ... Alachua, Fla. Mo-99 is the parent isotope ... nuclear medicine procedures worldwide. In 2012, Congress passed legislation ...
Breaking Medicine Technology:Clementia Pharmaceuticals Receives EMA Orphan Medicinal Product Designation for Palovarotene for the Treatment of Fibrodysplasia Ossificans Progressiva 2Clementia Pharmaceuticals Receives EMA Orphan Medicinal Product Designation for Palovarotene for the Treatment of Fibrodysplasia Ossificans Progressiva 3RedRick Technologies Helps Penn Radiology Implement New Radiology Reading Room Concepts 2RedRick Technologies Helps Penn Radiology Implement New Radiology Reading Room Concepts 3Coqui RadioPharmaceuticals Inks Deal With INVAP 2
... Trust, Inc. (NYSE: BMR ) announced ... with Omeros Corporation (NASDAQ: OMER ) ... Seattle, Washington.  A clinical-stage biopharmaceutical company committed to ... coagulopathies and disorders of the central nervous system, Omeros ...
... Feb. 1, 2012 Novartis announced today that following ... (FDA) has approved an update to the Gleevec ® ... of treatment after surgery for adult patients with KIT ... of recurrence inclusion criteria of the pivotal trial. This ...
Cached Medicine Technology:BioMed Realty and Omeros Sign New 64,500 Square Foot Lease in Seattle 2BioMed Realty and Omeros Sign New 64,500 Square Foot Lease in Seattle 3BioMed Realty and Omeros Sign New 64,500 Square Foot Lease in Seattle 4FDA approves Novartis drug Gleevec® label recommending extending treatment to three years for certain GIST patients after surgery 2FDA approves Novartis drug Gleevec® label recommending extending treatment to three years for certain GIST patients after surgery 3FDA approves Novartis drug Gleevec® label recommending extending treatment to three years for certain GIST patients after surgery 4FDA approves Novartis drug Gleevec® label recommending extending treatment to three years for certain GIST patients after surgery 5FDA approves Novartis drug Gleevec® label recommending extending treatment to three years for certain GIST patients after surgery 6FDA approves Novartis drug Gleevec® label recommending extending treatment to three years for certain GIST patients after surgery 7FDA approves Novartis drug Gleevec® label recommending extending treatment to three years for certain GIST patients after surgery 8
The Synoptiscope(L-2510B) has a wide variety of functions including binocular function diagnosis and treatment....
Inquire...
Security and confidence assured with porous tape; integral deodorizing/venting filter....
Inquire...
Medicine Products: